Molbio Diagnostics reported a consolidated profit of ₹58.7 crore for the quarter, reversing a loss of ₹23.7 crore in the year-ago period, with revenue growing nearly four-fold to ₹408.4 crore from ₹99.7 crore YoY. Despite the strong results, the company’s share price shed 2% amid broader market volatility on September 7.